企業プロフィール

Immix Biopharma 株価・ニュース・カタリスト

ティッカー:: IMMX
取引所:: NASDAQ
セクター:: Biopharma
所在地:: United States

株価パフォーマンス

11.34 USD (+3.37%)

終値

最終更新: 2026年8月17日

596M USD

時価総額

株価変動の要因

As of Aug 17, 2026, IMMX closed up 3.37% at $11.34. No new same-company headline was identified in the current news window.

企業概要

事業概要

Immix Biopharma is a biotechnology company focused on immune-driven therapies and oncology programs. Its strategy centers on translating immune biology into targeted treatment options.

所在地とセクター分類

Headquartered in the United States and listed on NASDAQ, Immix sits in specialty biotechnology.

ビジネスモデルの特徴

The company depends on clinical data, platform validation, and the ability to build a differentiated cancer story.

バイオ業界での位置付け

Immix is a catalyst-sensitive biotech name whose stock depends on early clinical progress.

今後のカタリスト

Immix’s catalysts are the oncology and immunology pipeline, especially any update that shows the company can still generate a clearer clinical path. The story remains early and data-dependent.